Search research articles
Contact Us
Filters
Showing results (1-10 of 186) with videos related to
Page
of 19
Sort By:
Current Problems in Cancer
|
April 11, 2017
The current status and problems confronted in delivering precision medicine in Japan and Europe
Hideaki Bando
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 16, 2012
[Predictive biomarkers for anti-EGFR antibodies]
Hideaki Bando, Takayuki Yoshino
JCO Precision Oncology
|
September 14, 2020
Precision Oncology and the Universal Health Coverage System in Japan
Hiromichi Ebi, Hideaki Bando
Med (New York, N.Y.)
|
January 10, 2026
STELLAR-303: Breaking the immunotherapy wall in MSS colorectal cancer
Hideaki Bando, Takayuki Yoshino
Japanese Journal of Clinical Oncology
|
November 5, 2015
Perspectives on research activity in the USA on Cancer Precision Medicine
Hideaki Bando, Naoko Takebe
Japanese Journal of Clinical Oncology
|
October 2, 2015
Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development
Hideaki Bando, Naoko Takebe
Frontiers in Oncology
|
August 1, 2018
The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
Kentaro Sawada, Daisuke Kotani, Hideaki Bando
Nature Reviews. Gastroenterology & Hepatology
|
January 20, 2023
Therapeutic landscape and future direction of metastatic colorectal cancer
Hideaki Bando, Atsushi Ohtsu, Takayuki Yoshino
Oncology (Williston Park, N.Y.)
|
July 21, 2021
Comparing GOZILA and COLOMATE: Ongoing Umbrella/Basket Trials Examining Genetic Testing in Gastrointestinal Malignancies
Hideaki Bando, Yoshiaki Nakamura, Daisuke Kotani, et al.
Med (New York, N.Y.)
|
September 13, 2025
From poor prognosis to precision promise: Clinical trials targeting BRAF-mutant metastatic colorectal cancer
Hironaga Satake, Hideaki Bando, Shin Kobayashi, et al.
Page
of 19
Search research articles
Search
Showing results (1-10 of 186) with videos related to
Sort By:
Page
of 19
Current Problems in Cancer
|
April 11, 2017
The current status and problems confronted in delivering precision medicine in Japan and Europe
Hideaki Bando
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 16, 2012
[Predictive biomarkers for anti-EGFR antibodies]
Hideaki Bando, Takayuki Yoshino
JCO Precision Oncology
|
September 14, 2020
Precision Oncology and the Universal Health Coverage System in Japan
Hiromichi Ebi, Hideaki Bando
Med (New York, N.Y.)
|
January 10, 2026
STELLAR-303: Breaking the immunotherapy wall in MSS colorectal cancer
Hideaki Bando, Takayuki Yoshino
Japanese Journal of Clinical Oncology
|
November 5, 2015
Perspectives on research activity in the USA on Cancer Precision Medicine
Hideaki Bando, Naoko Takebe
Japanese Journal of Clinical Oncology
|
October 2, 2015
Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development
Hideaki Bando, Naoko Takebe
Frontiers in Oncology
|
August 1, 2018
The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
Kentaro Sawada, Daisuke Kotani, Hideaki Bando
Nature Reviews. Gastroenterology & Hepatology
|
January 20, 2023
Therapeutic landscape and future direction of metastatic colorectal cancer
Hideaki Bando, Atsushi Ohtsu, Takayuki Yoshino
Oncology (Williston Park, N.Y.)
|
July 21, 2021
Comparing GOZILA and COLOMATE: Ongoing Umbrella/Basket Trials Examining Genetic Testing in Gastrointestinal Malignancies
Hideaki Bando, Yoshiaki Nakamura, Daisuke Kotani, et al.
Med (New York, N.Y.)
|
September 13, 2025
From poor prognosis to precision promise: Clinical trials targeting BRAF-mutant metastatic colorectal cancer
Hironaga Satake, Hideaki Bando, Shin Kobayashi, et al.
Page
of 19